LEADER 03471nam 22007333u 450 001 9910143260003321 005 20170816142724.0 010 $a1-280-19758-7 010 $a9786610197583 010 $a0-470-70410-1 010 $a0-470-75565-2 010 $a1-4051-4310-X 035 $a(CKB)1000000000351820 035 $a(EBL)233121 035 $a(OCoLC)475939824 035 $a(SSID)ssj0000158891 035 $a(PQKBManifestationID)11177926 035 $a(PQKBTitleCode)TC0000158891 035 $a(PQKBWorkID)10151596 035 $a(PQKB)10441729 035 $a(EXLCZ)991000000000351820 100 $a20131014d2008|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aFrom Naming to Saying$b[electronic resource] $eThe Unity of the Proposition 210 $aHoboken $cWiley$d2008 215 $a1 online resource (242 p.) 300 $aDescription based upon print version of record. 311 $a0-631-22655-9 327 $aFrom Naming to Saying: The Unity of the Proposition; Contents; Preface; Acknowledgments; Part I: Classical Theories of the Unity of the Proposition; 1 Frege's Account of the Unity of the Sentence; 2 Russell on the Analysis of the Sentence: Three Views; 3 Wittgenstein's Picture Theory of the Unity of the Proposition; Part II: Subjects and Predicates and their Logical and Metaphysical Correlates; 4 The Metaphysical Basis of the Subject-Predicate Distinction; 5 Negation, Propositional Combination, and the Nature of Concepts; 6 Can a Unified Theory of Predication Be Given? 327 $aPart III: A Pragmatic Account of the Unity of the Sentence7 The Causal Asymmetry between Subject and Predicate and the Unity of the Sentence; 8 Limitations, Applications, and Externalist Theories of Meaning; Bibliography; Index 330 $aFrom Naming to Saying explores the classicquestion of the unity of the proposition, combining an historical approach with contemporary causal theories to offer a unique and novel solution. Presents compelling and sophisticated answers to questions about how language represents the world. Defends a novel approach to the classical question about the unity of the proposition. Examines three key historical theories: Frege's doctrine of concept and object, Russell's analysis of the sentence, and Wittgenstein's picture theory of meaning. Combines an his 606 $aGrammar, Comparative and general 606 $aGrammar, Comparative and general - Sentences 606 $aProposition (Logic) 606 $aProposition (Logic) 606 $aProposition (Logic)$xSentences 606 $aGrammar, Comparative and general 606 $aPhilosophy$2HILCC 606 $aPhilosophy & Religion$2HILCC 606 $aLogic$2HILCC 608 $aElectronic books. 615 4$aGrammar, Comparative and general. 615 4$aGrammar, Comparative and general - Sentences. 615 4$aProposition (Logic). 615 4$aProposition (Logic). 615 0$aProposition (Logic)$xSentences 615 0$aGrammar, Comparative and general 615 7$aPhilosophy 615 7$aPhilosophy & Religion 615 7$aLogic 676 $a160 676 $a401.43 700 $aGibson$b Martha I$0873759 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910143260003321 996 $aFrom Naming to Saying$91950621 997 $aUNINA LEADER 02779nam 22006855 450 001 9910298324703321 005 20251105120425.0 010 $a3-319-00978-8 024 7 $a10.1007/978-3-319-00978-0 035 $a(CKB)2550000001166534 035 $a(EBL)1592324 035 $a(OCoLC)897576910 035 $a(SSID)ssj0001066480 035 $a(PQKBManifestationID)11585485 035 $a(PQKBTitleCode)TC0001066480 035 $a(PQKBWorkID)11067048 035 $a(PQKB)10347637 035 $a(MiAaPQ)EBC1592324 035 $a(DE-He213)978-3-319-00978-0 035 $a(PPN)176103503 035 $a(EXLCZ)992550000001166534 100 $a20131107d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aMolecular Vaccines $eFrom Prophylaxis to Therapy - Volume 2 /$fedited by Matthias Giese 205 $a1st ed. 2014. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2014. 215 $a1 online resource (434 p.) 300 $aDescription based upon print version of record. 311 08$a3-319-00977-X 311 08$a1-306-16576-8 320 $aIncludes bibliographical references and index. 327 $aNon-infectious and non-cancer vaccines -- Adjuvants and nanotechnology -- In silico and delivery systems -- Patenting, manufacturing, registration. 330 $aThis title discusses all aspects of non-infectious and non-cancer? so called NINC ? vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. Practical perspectives of patentability of vaccines are discussed. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application. 606 $aPharmacology 606 $aImmunology 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aPharmacology 606 $aImmunology 606 $aBiomedical Research 615 0$aPharmacology. 615 0$aImmunology. 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 14$aPharmacology. 615 24$aImmunology. 615 24$aBiomedical Research. 676 $a610 676 $a611.01816 676 $a615.372 676 $a615372 702 $aGiese$b Matthias$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910298324703321 996 $aMolecular Vaccines$92537239 997 $aUNINA